1283 related articles for article (PubMed ID: 32851443)
1. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
[TBL] [Abstract][Full Text] [Related]
2. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
3. Iron deposition and atrophy in cerebral grey matter and their possible association with serum iron in relapsing-remitting multiple sclerosis.
Al-Radaideh A; El-Haj N; Hijjawi N
Clin Imaging; 2021 Jan; 69():238-242. PubMed ID: 32977196
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal changes of deep gray matter shape in multiple sclerosis.
Tsagkas C; Geiter E; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Granziera C; Mallar Chakravarty M; Magon S
Neuroimage Clin; 2022; 35():103137. PubMed ID: 36002960
[TBL] [Abstract][Full Text] [Related]
5. Enlarged choroid plexus related to iron rim lesions and deep gray matter atrophy in relapsing-remitting multiple sclerosis.
Wang X; Zhu Q; Yan Z; Shi Z; Xu Y; Liu Y; Li Y
Mult Scler Relat Disord; 2023 Jul; 75():104740. PubMed ID: 37146422
[TBL] [Abstract][Full Text] [Related]
6. Subtyping relapsing-remitting multiple sclerosis using structural MRI.
Zhuo Z; Li Y; Duan Y; Cao G; Zheng F; Ding J; Tian D; Wang X; Wang J; Zhang X; Li K; Zhou F; Huang M; Li Y; Li H; Zeng C; Zhang N; Sun J; Yu C; Han X; Haller S; Barkhof F; Shi F; Liu Y
J Neurol; 2021 May; 268(5):1808-1817. PubMed ID: 33387013
[TBL] [Abstract][Full Text] [Related]
7. Quantitative T
Harper JG; York EN; Meijboom R; Kampaite A; Thrippleton MJ; Kearns PKA; Valdés Hernández MDC; Chandran S; Waldman AD;
Eur Radiol; 2024 Jun; 34(6):3826-3839. PubMed ID: 37943312
[TBL] [Abstract][Full Text] [Related]
8. New rapid, accurate T
Shepherd TM; Kirov II; Charlson E; Bruno M; Babb J; Sodickson DK; Ben-Eliezer N
Neuroimage Clin; 2017; 14():363-370. PubMed ID: 28239545
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio.
York EN; Meijboom R; Thrippleton MJ; Bastin ME; Kampaite A; White N; Chandran S; Waldman AD;
Neuroimage Clin; 2022; 36():103228. PubMed ID: 36265199
[TBL] [Abstract][Full Text] [Related]
10. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
[TBL] [Abstract][Full Text] [Related]
11. Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using three-dimensional (3D)-enhanced T2*-weighted angiography (ESWAN).
Du S; Sah SK; Zeng C; Wang J; Liu Y; Xiong H; Li Y
Eur J Radiol; 2015 Jul; 84(7):1325-32. PubMed ID: 25959392
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the heterogeneous pathological substrates of relapse-onset multiple sclerosis: a multiparametric voxel-wise 3 T MRI study.
Margoni M; Pagani E; Preziosa P; Gueye M; Azzimonti M; Rocca MA; Filippi M
J Neurol; 2023 Aug; 270(8):3839-3850. PubMed ID: 37093395
[TBL] [Abstract][Full Text] [Related]
13. Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Eshaghi A; Prados F; Brownlee WJ; Altmann DR; Tur C; Cardoso MJ; De Angelis F; van de Pavert SH; Cawley N; De Stefano N; Stromillo ML; Battaglini M; Ruggieri S; Gasperini C; Filippi M; Rocca MA; Rovira A; Sastre-Garriga J; Vrenken H; Leurs CE; Killestein J; Pirpamer L; Enzinger C; Ourselin S; Wheeler-Kingshott CAMG; Chard D; Thompson AJ; Alexander DC; Barkhof F; Ciccarelli O;
Ann Neurol; 2018 Feb; 83(2):210-222. PubMed ID: 29331092
[TBL] [Abstract][Full Text] [Related]
14. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
15. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
[TBL] [Abstract][Full Text] [Related]
16. Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?
Hernández-Torres E; Wiggermann V; Machan L; Sadovnick AD; Li DKB; Traboulsee A; Hametner S; Rauscher A
J Magn Reson Imaging; 2019 Jul; 50(1):201-208. PubMed ID: 30511803
[TBL] [Abstract][Full Text] [Related]
17. Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
Uddin MN; Lebel RM; Seres P; Blevins G; Wilman AH
Mult Scler; 2016 Aug; 22(9):1133-43. PubMed ID: 26503237
[TBL] [Abstract][Full Text] [Related]
18. Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Gracien RM; Jurcoane A; Wagner M; Reitz SC; Mayer C; Volz S; Hof SM; Fleischer V; Droby A; Steinmetz H; Groppa S; Hattingen E; Deichmann R; Klein JC
J Magn Reson Imaging; 2016 Dec; 44(6):1600-1607. PubMed ID: 27153293
[TBL] [Abstract][Full Text] [Related]
19. Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.
Gaetano L; Häring DA; Radue EW; Mueller-Lenke N; Thakur A; Tomic D; Kappos L; Sprenger T
Neurology; 2018 Apr; 90(15):e1324-e1332. PubMed ID: 29540589
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis.
Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
